Standard BioTools Inc. (FRA:FLB)

Market Cap	453.16M -38.0%
Revenue (ttm)	144.67M +79.8%
Net Income	-109.31M
EPS	-0.29
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	272
Open	1.160
Previous Close	1.180
Day's Range	1.160 - 1.160
52-Week Range	0.805 - 1.560
Beta	n/a
RSI	41.93
Earnings Date	Feb 6, 2026

About Standard BioTools

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software, and services based upon technologies used in the identification of proteins, as well as genes and their functions. The company provide...

• Industry: Laboratory Analytical Instruments
• Founded: 1999
• Employees: 818
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FLB

Financial Performance

In 2024, Standard BioTools's revenue was $174.43 million, an increase of 64.03% compared to the previous year's $106.34 million. Losses were -$184.90 million, 147.7% more than in 2023.

Financial numbers in USD